Smolen JS, et al : EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs :2016 update. Ann Rheum Dis (2017), doi:10.1136/annrheumdis-2016-210715 [Epub ahead of print]
Takahashi C, Kaneko Y, et al :Association of erythrocyte methotrexate-polyglutamate levels with the efficacy and hepatotoxicity of methotrexate in patients with rheumatoid arthritis: a 76-week prospective study. RMD Open, 3 (1), e000363 (2017), doi:10.1136/rmdopen-2016-000363
Burmester GR, et al : Efficacy and safety of ascending methotrexate dose in combination with adalimumab : the randomised CONCERTO trial. Ann Rheum Dis, 74 (6), 1037-1044 (2015)
Kaeley GS, et al: Changes in Ultrasonographic Vascularity Upon Initiation of Adalimumab Combination Therapy in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate. Arthritis Rheumatol, 68 (11), 2584-2592 (2016)